BioInfinity score history

Score over time

Every entry newest first

1. October 25, 2026Lowered from3.71→to3.70(-0.01)

   Pricing recomputed on 25 October 2026: listings added for a newly reviewed vendor (Pexo Labs) moved the market median for the same products: pricing 5.4 to 5.3.

2. October 24, 2026Raised from3.70→to3.71(+0.01)

   Pricing recomputed on 24 October 2026: listings added for newly reviewed vendors moved the market median for the same products: pricing 5.3 to 5.4.

3. October 23, 2026Lowered from3.71→to3.70(-0.01)

   Pricing recomputed on 23 October 2026 from current listings with the published rule (section E), after listings added or updated since 22 October, including a newly reviewed vendor's, moved the market median for the same products: pricing 5.4 to 5.3.

4. October 22, 2026Lowered from3.86→to3.71(-0.15)

   Re-scored on 22 October 2026 under the published rulebook, which now gives one rule for each judgement call and applies it to every vendor: shipping and refunds 8.5 to 7.5, transparency 5.0 to 6.0.

5. October 22, 2026Re-checked, no change (3.86)

   Re-scored on 22 October 2026 under version 2 of our published rules. No score change. The testing gate is now computed from the certificates instead of set by hand: 0 of 17 products have a certificate from a directory laboratory with the key confirmed at the laboratory, fewer than the half required, so the testing cap applies; the cap sits above the weighted score, so it does not lower it.

6. October 22, 2026Lowered from4.44→to3.86(-0.58)

   Re-scored on 22 October 2026 under our published rubric for shipping, pricing, operating history and transparency, applied to every vendor the same day: prices re-read from the vendor's site and matched by milligrams per vial, operating history from the earliest dated evidence of the business, and policies scored item by item. shipping and refunds 9.5 to 8.5, pricing 7.2 to 5.4, transparency 7.1 to 5.0.

7. October 22, 2026Lowered from4.54→to4.44(-0.10)

   Lab score recalculated on 22 October 2026 under the uniform published rubric applied to every vendor: the DSIP and CJC-1295/Ipamorelin records now linked from the product pages are counted; every certificate comes from Verum Analytics, which we could not establish as an independent laboratory, so each scores the fixed 2.0; fixed deductions apply for one lot number printed on certificates for different compounds. Lab 2.0 to 1.8.

8. October 22, 2026Lowered from7.31→to4.54(-2.77)

   Lab evidence and pricing re-checked on 22 October 2026. The certificate records come from verumlab.ch, which we could not establish as an independent laboratory (domain registered after most of its reported analysis dates; every record is for BioInfinity Lab and is built into the site's own code), so lab moves from 6.4 to 2.0 and the third-party testing cap applies. Pricing moves from 9.5 to 7.2 on a fresh comparison with the market median.

9. October 21, 2026Lowered from8.48→to7.31(-1.17)

   Lab 8.3 to 6.4 and tenure 4.6 to 2.2. Recomputed under our published rule, which averages the lab score over the products we list and counts a listed product with no certificate as zero. DSIP and the CJC-1295/Ipamorelin blend count as having no certificate: an automated backfill on 18 October 2026 had restored a DSIP record that our 8 October correction removed, and that reversal has been undone. The Verum records could not be confirmed at the laboratory. Both domains were registered in August and September 2025, so tenure was aligned to that age.

10. October 8, 2026Re-checked, no change (8.48)

    The DSIP entry in the COA library carries no document, so Janoshik was not added to the roster and our own incorrect Verum certificate record for that product was removed. The footer claim that all products are verified by Verum Analytics is contradicted by that same row.

11. July 23, 2026Raised from8.40→to8.48(+0.08)

    Re-audited from live COAs. Verified 44 Verum Analytics reports (A-tier: purity, identity, content, endotoxin, with a public verify portal), affirming the high lab credit. Note added 22 October 2026: under the laboratory checks published that day, Verum Analytics is graded tier D: its existence and independence are not established (checks L1 and L2), so its certificates score a flat 2.0.